A Randomized Phase II Study of SUBATM-itraconazole in Patients With Untreated Squamous NSCLC.
Clinical trial NCT01752023 · TERMINATED
Trial details
- NCT number
- NCT01752023
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2014-04-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.